NKG2D-bispecific enhances NK and CD8+ T cell antitumor immunity
Cancer Immunology, Immunotherapy · 08.08.2024 · 73 (10)
DOI: 10.1007/s00262-024-03795-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, online erschienen am 08.08.2024. Verfasst von Aurelie Herault und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Oncology, Genentech, South San Francisco, CA, USA. Hauptthemen laut MEDLINE: NK Cell Lectin-Like Receptor Subfamily K, CD8-Positive T-Lymphocytes, Killer Cells, Natural, Breast Neoplasms. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Oncology, Genentech, South San Francisco, CA, USA.
- Department of Biochemical and Cellular Pharmacology, Genentech, South San Francisco, CA, USA.
- Department of Antibody Engineering, Genentech, South San Francisco, CA, USA.
- Department of In Vivo Pharmacology, Genentech, South San Francisco, CA, USA.
- Immuno-Oncology-In Vitro Biology Department, Evotec, Toulouse, France.
- Department of Cancer Immunology, Genentech, South San Francisco, CA, USA.
Zitieren
APA
Herault, A., Mak, J., de la Cruz-Chuh, J., Dillon, M. A., Ellerman, D., Go, M., Cosino, E., Clark, R., Carson, E., Yeung, S., Pichery, M., Gador, M., Chiang, E. Y., Wu, J., Liang, Y., Modrusan, Z., Gampa, G., Sudhamsu, J., Kemball, C. C., …, & Walsh, K. B. (2024). NKG2D-bispecific enhances NK and CD8+ T cell antitumor immunity. Cancer Immunology, Immunotherapy, 73(10). https://doi.org/10.1007/s00262-024-03795-2
Vancouver
Herault A, Mak J, de la Cruz-Chuh J, Dillon MA, Ellerman D, Go M, et al. NKG2D-bispecific enhances NK and CD8+ T cell antitumor immunity. Cancer Immunology, Immunotherapy. 2024;73(10). doi:10.1007/s00262-024-03795-2
BibTeX
@article{Herault2024,
author = {Herault, Aurelie and Mak, Judy and de la Cruz-Chuh, Josefa and Dillon, Michael A and Ellerman, Diego and Go, MaryAnn and Cosino, Ely and Clark, Robyn and Carson, Emily and Yeung, Stacey and Pichery, Melanie and Gador, Mylène and Chiang, Eugene Y and Wu, Jia and Liang, Yuxin and Modrusan, Zora and Gampa, Gautham and Sudhamsu, Jawahar and Kemball, Christopher C and Cheung, Victoria and Nguyen, Thi Thu Thao and Seshasayee, Dhaya and Piskol, Robert and Totpal, Klara and Yu, Shang-Fan and Lee, Genee and Kozak, Katherine R and Spiess, Christoph and Walsh, Kevin B},
title = {NKG2D-bispecific enhances NK and CD8+ T cell antitumor immunity},
journal = {Cancer Immunology, Immunotherapy},
year = {2024},
volume = {73},
number = {10},
doi = {10.1007/s00262-024-03795-2}
}
EUVIMED